订阅小程序
旧版功能
研究兴趣

论文共 405 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Cardiovascular Disease Risk Estimates in the US CKD Population Using the PREVENT Equation
Carl P Walther, L Parker Gregg,Sankar D Navaneethan
American journal of kidney diseases the official journal of the National Kidney Foundationno. 1 (2025): 10-17
引用0浏览0WOS引用
0
0
Efficacy and Safety of Finerenone in Patients with an Acute Change in Estimated Glomerular Filtration Rate in the Prespecified FIDELITY Pool Analysis
Sankar D Navaneethan, Stefan D Anker,Gerasimos Filippatos,Bertram Pitt,Peter Rossing, Luis M Ruilope,Phyllis August, Meike Brinker,Andrea Lage,Luke Roberts,Charlie Scott, Pantelis Sarafidis, FIDELIO-DKD and FIGARO-DKD Investigators
Kidney internationalno. 1 (2025): 136-144
引用0浏览0WOS引用
0
0
Hyperkalemia Risk of Finerenone Versus Spironolactone in CKD Patients with Type 2 Diabetes
Abiodun Idowu,Kevin Bryan Lo, Olayinka Adebolu, Michael Hamilton, Peter Abdelmaseeh,Sankar D Navaneethan,Janani Rangaswami
Nephrology, dialysis, transplantation official publication of the European Dialysis and Transplant Association - European Renal Association (2025)
引用0浏览0WOS引用
0
0
Therapeutic Approaches for Pulmonary Hypertension in Patients with Chronic Kidney Disease
Marcelle Tuttle,Mark J Sarnak,Sankar D Navaneethan
Current opinion in nephrology and hypertensionno. 5 (2024): 494-502
引用0浏览0WOS引用
0
0
加载更多
作者统计

#Papers: 409

#Citation: 31912

H-Index: 66

G-Index: 177

Sociability: 8

Diversity: 3

Activity: 61

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn